BNY Mellon Small/Mid Cap Growth Fund Class C DBMCX

Medalist Rating as of | See BNY Mellon Investment Hub
  • NAV / 1-Day Return 14.96  /  −0.80 %
  • Total Assets 821.7M
  • Adj. Expense Ratio
    1.860%
  • Expense Ratio 1.810%
  • Distribution Fee Level Average
  • Share Class Type Level Load
  • Category Mid-Cap Growth
  • Investment Style Small Growth
  • Min. Initial Investment 1,000
  • Status Open
  • TTM Yield 0.00
  • Turnover 131%

USD | NAV as of Jul 11, 2026 | 1-Day Return as of Jul 11, 2026, 12:11 AM GMT+0

Morningstar’s Analysis DBMCX

Will DBMCX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

BNY Mellon Sm/Md Cp Gr C holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings DBMCX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 31.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Guardant Health Inc

4.42 36M
Healthcare

Repligen Corp

3.46 28M
Healthcare

The Baldwin Insurance Group Inc Class A

3.30 27M
Financial Services

MKS Inc

3.23 26M
Technology

Construction Partners Inc Class A

3.18 26M
Industrials

Curtiss-Wright Corp

2.88 23M
Industrials

Herc Holdings Inc

2.65 22M
Industrials

Wingstop Inc

2.65 22M
Consumer Cyclical

Bel Fuse Inc Class B

2.64 22M
Technology

Casey's General Stores Inc

2.64 22M
Consumer Cyclical

Sponsor Center